Avastin (bevacizumab) Clinical Research
(Avastin) Combined with Chemotherapy Prolongs Survival in Some Patients
with NSCLC (National Cancer Institute)
Discusses preliminary results from a large, randomized clinical trial
for previously untreated non-squamous cell NSCLC patients that showed
bevacizumab (Avastin) in combination with standard chemotherapy lived
longer than patients who received the same chemotherapy without Avastin.
and Antiangiogenic Therapy: What Can Be Expected of Bevacizumab?
by Roy S. Herbst and Alan B. Sandler
v.9,Suppl.1 The Oncologist (June 1, 2004): 19-26
Explains the process of antiangiogenesis in lung cancer, focusing
on the experience with bevacizumab in a promising Phase II trial. Discusses
the main toxicity concerns with the use of bevacizumab in NSCLC. [6/04]
- Recent MEDLINE Abstracts (PubMed)
Clinical Trials (ClinicalTrials.gov)
Avastin (bevacizumab) Side Effects
Factsheet describes Avastin (bevacizumab), how it is given, possible
side effects, precautions and self-care tips.